Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Patient-reported outcomes in N1 breast cancer: A phase III trial comparing whole-breast to whole-breast plus regional irradiation after taxane-based chemotherapy (KROG 1701).2024
2Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate CancerOriginal Research · 2023 · 21 citations
3Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp TrialRCT · 2026 · 1 citations
4Implementation of patient reported outcomes as nonmuscle-invasive bladder cancer clinical trial endpoints.Human Clinical Trial · 2026
5Patient‐reported outcomes as non‐muscle‐invasive bladder cancer clinical trial endpointsClinical Trial · 2026
6Association of routine electronic symptom monitoring with reduced opioid use in patients with head and neck cancers.cohort · 2026
7Abstract PO3-10-10: Are we adequately integrating patient reported outcomes in breast cancer clinical trials?2024 · 1 citations
8Electronic patient-reported outcome assessment at inpatient admission: a descriptive analysis of real-world data for 1423 radiotherapy patientsOriginal Research · 2026
9Escalation of Resting Heart Rate and Tachycardia as a Response to Thoracic Radiotherapy: Implications for Cardiovascular Outcomes after RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics · 2026
10Proton Therapy for Breast, Prostate, and Leptomeningeal Disease—Some Answers, but Questions PersistInternational Journal of Radiation Oncology*Biology*Physics · 2026

More from International Journal of Radiation Oncology*Biology*Physics

More from Harvard University